Formulations utilizing high-potent APIs is one of the Gen-Plus key competencies. Over 60 drug products of cytostatics, immunosuppressives and kinase inhibitors (OEB 4-5) were developed for customers so far. Recently the company accomplished the manufacturing permit for high-potent Clinical Trial Supplies. Please consider us as your high potent center of excellence!

Related Posts

  • From Houston to Munich – Innovation & Compounding

    read more

  • Gen-Plus donates € 10,000 to the Pro Retina Foundation

    read more

  • We wish all business partners a Merry Christmas and a healthy, happy 2023.

    read more